CanSino raises $10M from Lilly Asia Ventures

Vaccine company Tianjin CanSino Biotechnology Inc. (Tianjin, China) raised $10 million in a financing from Lilly Asia Ventures. CanSino, which was established in 2009, is developing vaccines for pertu...